Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ube Material Industries, a subsidiary of Ube Corporation, is a prominent Japanese manufacturer of high-purity inorganic materials derived from limestone and seawater. The company is a critical supplier to the pharmaceutical industry, producing magnesium hydroxide and magnesium oxide which serve as active pharmaceutical ingredients (APIs) for laxatives and antacids. Beyond gastrointestinal health, Ube Material Industries develops advanced bioceramics, including hydroxyapatite and tricalcium phosphate, for use in bone grafts and dental fillers. Their manufacturing processes are characterized by high-purity synthesis, supporting the stringent requirements of the global healthcare and medical device markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ube Material Industries.